PROCEPT BioRobotics (PRCT) Receivables - Net (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Receivables - Net data on file, last reported at $96.4 million in Q1 2026.

• On a quarterly basis, Receivables - Net rose 21.6% year-over-year to $96.4 million in Q1 2026; TTM through Mar 2026 was $96.4 million, a 21.6% increase from a year earlier, with the FY2025 full-year figure at $83.5 million, changed 0.04% from the prior year.
• Receivables - Net for Q1 2026 stood at $96.4 million, up from $83.5 million in the prior quarter.
• Over the last five years, Receivables - Net for PRCT reached as high as $96.4 million in Q1 2026 and fell as low as $7.0 million in Q1 2022.
• Historically, Receivables - Net has averaged $51.5 million across 5 years, with a median of $56.1 million in 2024.
• Across the five-year window, Receivables - Net soared 242.11% in 2022 and climbed 0.04% in 2025, its largest moves.
• Year by year, Receivables - Net stood at $15.3 million in 2022, then jumped by 216.76% to $48.4 million in 2023, then soared by 72.6% to $83.5 million in 2024, then rose by 0.04% to $83.5 million in 2025, then gained by 15.39% to $96.4 million in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $96.4 million in Q1 2026, $83.5 million in Q4 2025, and $84.5 million in Q3 2025.